ProteusDx™

Why GI Practices Adopt ProteusDx™

An AI-Enhanced Extension of the Procedural GI Practice

1. From Blind Spots to Full-GI Visibility

Traditional EGD and colonoscopy remain essential. However, they leave a significant diagnostic gap in the small bowel and offer limited ability to monitor mucosal change over time without repeat procedures.

ProteusDx™ enables:

  • Complete small bowel visualization without sedation
  • AI-assisted identification of inflammation, bleeding patterns, and mucosal abnormalities
  • Structured lesion mapping that complements traditional endoscopic findings

Clinical Impact: For GI practices, this transforms capsule endoscopy from a niche test into a core diagnostic extension of procedural care.

2. AI That Reduces Review Burden, Not Clinical Control

One of the historical barriers to capsule adoption has been time-intensive image review. ProteusDx™ addresses this directly.

ProteusDx™ enables:

  • AI-prioritized image streams that surface clinically relevant frames
  • Visual heatmaps and pattern clustering to guide physician review
  • Decision-support insights that highlight change over time

Clinical Impact: Importantly, ProteusDx™ does not replace physician judgment. It shortens review time, improves consistency, and allows gastroenterologists to focus on interpretation rather than manual screening.

3. Smarter Triage Into the Endoscopy Suite

ProteusDx™ functions as an upstream intelligence layer for procedural care.

ProteusDx™ enables:

  • Identify which patients genuinely require invasive procedures
  • Reduce low-yield diagnostic endoscopies
  • Escalate patients with visual evidence of pathology, not symptoms alone

Clinical Impact: This results in better utilization of procedure rooms, improved case mix, and higher clinical yield per intervention.

4. Decentralized Diagnostics Without Losing Oversight

ProteusDx™ allows capsule deployment in multiple settings while maintaining centralized clinical control.

ProteusDx™ allows capsule deployment in:

  • The GI clinic
  • Referring practices
  • The patient's home, when appropriate

Despite decentralization, the GI practice retains:

  • Full clinical oversight
  • Centralized AI-assisted review
  • Standardized reporting and follow-up pathways

Clinical Impact: This expands diagnostic capacity without increasing staffing, recovery bays, or anesthesia dependency.

5. Longitudinal Monitoring Without Repeat Sedation

Chronic GI conditions often require repeated evaluation, yet frequent invasive procedures increase cost, risk, and patient resistance.

ProteusDx™ enables:

  • Baseline visualization followed by interval monitoring
  • AI-assisted comparison across timepoints
  • Early detection of progression or resolution

Clinical Impact: For GI practices, this introduces a monitoring model that complements episodic procedures and supports modern chronic care pathways.

6. Strong Patient Acceptance Drives Earlier Engagement

Patients increasingly seek diagnostics that are non-invasive, convenient, and transparent.

ProteusDx™ improves patient engagement by:

  • Eliminating sedation and recovery time
  • Allowing patients to visualize their own GI findings
  • Reducing fear-based avoidance of care

Clinical Impact: Earlier engagement leads to more appropriate downstream procedures, not fewer.

7. Financial and Strategic Upside for GI Practices

ProteusDx™ creates incremental value without cannibalizing core procedures.

ProteusDx™ creates value by:

  • Adding reimbursable or cash-pay diagnostic services
  • Increasing referral inflow from primary care and wellness channels
  • Improving procedural yield and reducing negative scopes

Clinical Impact: Practices gain new revenue streams while strengthening their procedural backbone.

Positioning Summary for GI Leaders

ProteusDx™ positions capsule endoscopy as:

  • A clinical intelligence layer, not a commodity device
  • An AI-accelerated extension of the endoscopy suite
  • A patient-friendly front door into procedural GI care

For GI practices accustomed to hospital or ASC-based procedures, ProteusDx enables a shift from episodic intervention to continuous, data-informed GI management, without sacrificing clinical authority or procedural relevance.